Back to Overview

Product Details

What does BCDDS offer?

What are the advantages of using BCDDS?

Which patient cases benefit most from using BCDDS?

How is BCDDS integrated into a clinical environment?

What does BCDDS offer?

BCDDS has been designed with radiologists for radiologists with a goal of optimal ease-of-use in the medical community. BCDDS is particularly effective in detecting and locating breast cancer in three-dimensional space in difficult cases. BCDDS helps:

• Determine the presence or absence of breast cancer.
• Determine the three-dimensional location of malignancies and other structures within the breast.
• Reduce the probability of false positives associated with MRI of the breast, especially for benign fibroadenomas and cases with earlier wounding of the breast from biopsy or recent surgical reconstruction.
• Discriminate among kinds of malignancies that have been located.
• Determine whether malignancies are uni- or multi-focal, which aids in staging.
• Obtain reliable estimates of tumor volumes, which aids in determining whether a tumor is growing, shrinking, or remaining the same size.

Back to Top

What are the advantages of using BCDDS?

BCDDS uses the latest technological solutions to help find, locate, and visualize even very small, very early breast cancers. BCDDS excels in yielding reliable estimates of both the extent and size of abnormalities. These results are useful in answering questions of staging, treatment course, and case follow-up.

Unique features of BCDDS include:

• Dynamic MRI 4th-dimensional analysis.
• True interactive 3D visual representation of the entire breast volume; all image data is visible simultaneously.
• Three, two-dimensional cross-referenced views, interactively cross-linked to 3D view.
• Interactive Dynamic Curve Computation (IDCC) for various known malignancies and fibroadenomas.
• Automatic calculation of malignant tissue volumes.

The display in BCDDS is especially effective in understanding the volumetric nature of a data set. In addition to augmenting existing 2D techniques, we add a powerful 3D visualization. While maximum intensity projection (MIP) is a useful and common 3D visualization technique, it shows only the brightest portion of a data set. Our 3D visualization shows complete data sets that may be manipulated (rotated, panned, and zoomed) by the user at interactive frame rates.

BCDDS is designed to be reliable, accurate, and efficient. It is easy to learn and intuitive to use, and can quickly help in breast cancer detection and localization of abnormalities. Training requires less than two days (12 hours or less), and follow-up support is available.

Back to Top

Which patient cases benefit most from using BCDDS?

BCDDS is designed to reduce the time requirements and increase the thoroughness of detection of breast cancer in certain difficult clinical cases. These cases include:

• Mammographically occult and ultrasonically anomalous cases in which clinical suspicion is high.
• Women with a family history of breast cancer.
• Women who carry the BRCA1 or BRCA2 breast cancer gene.
• Women with dense breasts, especially younger patients.
• Women who have had breast cancer and have had reconstructive surgery with implants, or women who have had breast augmentation.

Back to Top

How is BCDDS integrated into a clinical environment?

BCDDS uses the temporal characteristics of chelated gadolinium to help determine the kind and extent of breast cancers, such as ductal cancer in situ, invasive ductal cancer, lobular cancer, and inflammatory breast cancer. BCDDS is robust, handling large 3D data set (e.g. bilateral data sets containing 1000 512x512 images).

BCDDS is fully DICOM3 compliant and will work with any suitable MRI scanner equipped with a MRI breast coil. BCDDS works with unilateral and bilateral breast image acquisition series. Because of processing and visualization requirements, BCDDS is shipped as a stand-alone system that may be connected to a radiological network.

Back to Top

*PATENT PENDING